Zoetis says FDA grants emergency use authorization for Simparica Trio to treat New World screwworm in dogs

• Zoetis won FDA Emergency Use Authorization for Simparica Trio to treat New World screwworm infestations in dogs and puppies.
• Authorization targets myiasis caused by Cochliomyia hominivorax larvae as the parasite threat grows in the US.
• Use is limited to the emergency declaration period; Simparica Trio is not otherwise approved for this indication.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zoetis Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260813903513) on August 13, 2026, and is solely responsible for the information contained therein.